Recent Articles

• Exploring the Growth and Innovations in 3D & 4D Technology
• Brian Levin Appointed Chief Revenue Officer at Reality Defender
• Horizon Aircraft to Engage Investors at Upcoming Key Conferences
• Discovering New Frontiers in Cancer Therapy with LIXTE's LB-100
• C3is Inc. Set to Share Progress in Seaborne Transportation
• Septerna's Strategic Moves in Upcoming Investor Conferences
• Protara Therapeutics Engages with Investors at Key Conferences
• Nautilus Biotechnology Prepares for September Investor Conferences
• RAPT Therapeutics Engages Investors Through Key Healthcare Events
• Innovative Advances in Niemann-Pick Disease Treatment Showcase
• Design Therapeutics Discusses Innovations at Upcoming Conference
• Soleno Therapeutics Gears Up for Key Upcoming Investor Events
• SunCar Technology and NIO: Innovating Auto Insurance Services
• MiMedx Group's Engagements at Upcoming Investor Conferences
• U.S. Gold Corp. Partners with Cheyenne Light for CK Gold Project
• Northern 3 VCT PLC Announces Share Purchase for Cancellation
• Greenlane Renewables Secures Over $1.3 Million in RNG Deals
• Northern Venture Trust PLC Announces Share Buyback Activity
• Aclaris Therapeutics Set to Showcase Innovations at Conferences
• Northern 2 VCT PLC Announces Share Buyback for Cancellation
• BioXcel Therapeutics Pivotal Trial Shows Promising Results for BXCL501
• Aclaris Therapeutics to Attend September Healthcare Events
• BioXcel Therapeutics Achieves Critical Milestone with BXCL501
• Emergent BioSolutions: Key Insights on Upcoming Conferences
• Slide Insurance Announces Significant Stock Repurchase Strategy
• ECARX's $1 Billion Global Contracts Boost Long-Term Growth
• Mynd.ai Reports Impressive H1 2025 Financial Results
• Evaxion A/S: Upcoming Conference Presentations and Engagements
• Investigating Encompass Health: What Investors Need to Know
• Emergent BioSolutions Gears Up for Key Investor Conferences
• Cellectar Biosciences to Share Pediatric Cancer Research Insights
• Blazing Star Merger Sub Extends Tender Offer for Walgreens Notes
• NRx Pharmaceuticals Expands Access to Innovative Ketamine Therapy
• Kailera Therapeutics Announces Engagement in Key Investor Events
• Unlocking the Sleep Benefits of Walnuts for Young Adults
• Sompo's Strategic Acquisition of Aspen Insurance Holdings
• Sempra Infrastructure and EQT Forge Long-Term LNG Supply Deal
• Cellectar Biosciences to Showcase Promising Pediatric Cancer Data
• The9 Limited's GameFi Platform Reaches 1 Million Users Quickly
• Commerce Secretary Lutnick Announces Blockchain GDP Initiative
• MannKind and United Therapeutics Strengthen Partnership for New Therapy
• World Youth Clubs Welcomes Two Esteemed Leaders to Board
• Notable Stocks Under Pressure: JM Smucker and Baidu React
• Sez Us Welcomes New CEO as Company Expands Globally
• Top Analysts Highlight Three High-Dividend Stocks in Telecom
• Actinogen Medical's Xanamem Trial Shows Positive Results
• Castillo Hermanos' Nutrition Program Transforms Lives in Guatemala
• Valour Expands ETP Offering with Eight New Digital Assets
• YouTube TV Welcomes One America News and AWE to Lineup
• Mynd.ai Reports Strong 2025 First Half Financials